Lottery.com and Sports.com Headline Soccerex Europe 2025 as Title Sponsor in Amsterdam
FORT WORTH, Texas, May 20, 2025 (GLOBE NEWSWIRE) -- Lottery.com Inc. (NASDAQ: LTRY, LTRYW) ('Lottery.com' or the 'Company'), a leading technology company transforming the intersection of gaming, sports and entertainment, is proud to announce its role as Title Sponsor of Soccerex Europe 2025, taking place from May 19–21 at the iconic Johan Cruyff Arena in Amsterdam.
As headline sponsor of this globally recognized football business summit, Lottery.com and its media platform Sports.com will be front and center across the event's programming, branding, and panel content. With over 800 influential attendees expected—including former players, club owners, league officials, and investors—Soccerex Europe 2025 marks a major stage in Lottery.com's international growth strategy.
Marc Bircham, Director of Lottery.com and Sports.com, and Tamer Hassan, Director of Lottery.com and renowned actor, will represent the group across two high-impact panel sessions:
Day 1 | May 19 | 2:00–2:45 PMPanel: The Future of Football Media & Fan EngagementStage 1 | Moderated by Mark LomasMarc Bircham and Tamer Hassan will share insights into how platforms like Sports.com are driving innovation in fan experiences, immersive content, and club ownership models.
Day 2 | May 20 | Time TBCPanel: Beyond the Pitch – Prioritizing Player Care & Wellness in Modern FootballModerated by ESPN Correspondent Cecilia LagosMarc Bircham joins a distinguished panel including Betsy Cutler (VP, Wellness & Safeguarding, USL), Anna Pereira (CEO, The Wellness Universe), and Vincent Gouttebarge (Chief Medical Officer, FIFPRO), discussing the increasing responsibility of clubs, leagues, and media to protect player wellbeing on and off the field.
Sports.com branding will be fully integrated across the venue, including:
Main screen features during the exclusive VIP Night on the pitch
Step-and-repeat media walls and photo zones
Event-wide activations, mirroring the success of the brand's visibility at Soccerex Cairo
'We're here to lead—not just participate,' 'From immersive fan experiences to meaningful conversations around player care, Sports.com is establishing itself as a progressive force in football.'
'I'm honored to represent Sports.com at such a prestigious event,' said Tamer Hassan, Director at Lottery.com and acclaimed actor. 'Soccerex brings together the best minds in global football, and I'm proud to contribute to conversations that are shaping the future of the game—both on and off the pitch. Sports.com is building something truly special, and it's a privilege to be part of that journey.'
A stellar lineup of football legends—including Mikaël Silvestre, Ronald de Boer, Dani, Emerson Boyce, Gabriel Heinze, and others—will also be in attendance, adding to the event's prestige.
Alongside Lottery.com, other event sponsors include KNVB, La Liga, Minute Media, Special Olympics, SofaScore, Zenith Coins, Weaver Labs, and Sports Hotels.
Further updates and behind-the-scenes coverage will be released live from Amsterdam throughout the week.
About Lottery.com
The Lottery.com Inc. (NASDAQ: LTRY, LTRYW) family of brands — including Sports.com, Tinbu, and WinTogether, is a unified ecosystem that integrates gaming, entertainment, and sports.
Important Notice Regarding Forward-Looking Statements
This press release contains statements that constitute 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of present or historical fact included in this press release, regarding the Company's strategy, future operations, prospects, plans and objectives of management, are forward-looking statements. When used in this Form 8-K, the words 'could,' 'should,' 'will,' 'may,' 'believe,' 'anticipate,' 'intend,' 'estimate,' 'expect,' 'project,' 'initiatives,' 'continue,' the negative of such terms and other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. These forward-looking statements are based on management's current expectations and assumptions about future events and are based on currently available information as to the outcome and timing of future events. The forward-looking statements speak only as of the date of this press release or as of the date they are made. The Company cautions you that these forward-looking statements are subject to numerous risks and uncertainties, most of which are difficult to predict and many of which are beyond the control of the Company. In addition, the Company cautions you that the forward-looking statements contained in this press release are subject to risks and uncertainties, including but not limited to, any future findings from ongoing review of the Company's internal accounting controls, additional examination of the preliminary conclusions of such review, the Company's ability to secure additional capital resources, the Company's ability to continue as a going concern, the Company's ability to respond in a timely and satisfactory matter to the inquiries by Nasdaq, the Company's ability to regain compliance with the Bid Price Requirement, the Company's ability to regain compliance with Nasdaq Listing Rules, the Company's ability to become current with its SEC reports, and those additional risks and uncertainties discussed under the heading 'Risk Factors' in the Form 10-K/A filed by the Company with the SEC on April 22, 2025, and the other documents filed, or to be filed, by the Company with the SEC. Additional information concerning these and other factors that may impact the operations and projections discussed herein can be found in the reports that the Company has filed and will file from time to time with the SEC. These SEC filings are available publicly on the SEC's website at www.sec.gov. Should one or more of the risks or uncertainties described in this press release materialize or should underlying assumptions prove incorrect, actual results and plans could differ materially from those expressed in any forward-looking statements. Except as otherwise required by applicable law, the Company disclaims any duty to update any forward-looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date of this press release.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5bc45e72-8575-4110-b143-2df9bf3983cd
This press release was published by a CLEAR® Verified individual.
CONTACT: For more information, please visit www.lottery.com or www.sports.com or contact our media relations team at press@lottery.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
Meet the Monster Stock That Continues to Crush the Market
Key Points Palantir has been seeing accelerating revenue growth as customers adopt its AI platform. While the stock is pricey, it has an enormous opportunity still in front of it. 10 stocks we like better than Palantir Technologies › Palantir Technologies (NASDAQ: PLTR) has been the single best-performing stock in the not just this year, but last year as well. The artificial intelligence (AI) leader more than doubled in 2025 through mid-August, on top of a stunning 340% gain in 2024. That kind of back-to-back performance is almost unheard of, and it's no accident. The company is growing at a blistering pace, landing massive new contracts and rapidly expanding the reach of its Artificial Intelligence Platform (AIP). With momentum this strong, it's worth looking at exactly what's driving the surge, what could slow it down, and why the long-term opportunity remains enormous. What Palantir does Palantir made a name for itself in the years after 9/11, providing advanced data analytics to U.S. intelligence agencies. It built a reputation for solving complex, high-stakes problems, with the government using it to fight terrorism and later track COVID cases. The U.S. federal government remains Palantir's largest customer, but its biggest growth engine is now the commercial sector. Palantir's secret sauce is AIP. The solution collects data from a multitude of sources, organizes it into what it calls an "ontology," and connects it to real-world assets and processes. This gives AI models the clean source of data they need to help solve real-world problems. Palantir is not building large language models (LLMs), instead it is providing the system that gives organizations the tools to make AI actually work. In essence, AIP is like an AI operating system. Strong growth Palantir's results speak for themselves. The company has seen its revenue growth accelerate for eight straight quarters. In Q2, its revenue soared 48% year over year to $1 billion. U.S. commercial revenue jumped 93% to $306 million, with customer count up 43% from a year ago. Remaining deal value in that segment more than doubled to $2.79 billion, showing just how quickly adoption is growing. Existing customers are also expanding quickly, with net dollar retention climbing to 128%. (Any number north of 100% means a company saw growth from existing customers, net of any churn.) The government side is equally strong. U.S. government revenue surged 53% to $426 million in Q2, and Palantir landed a 10-year, $10 billion Army contract consolidating 75 agreements into one. International government sales grew 37%. Risks No stock is risk-free, and the most obvious risk for Palantir is its valuation. The stock trades at a forward price-to-sales (P/S) ratio of nearly triple digits, and its price-to-earnings (P/E) multiple is nearing 275. Even if the stock were cut in half, it would still be far from cheap. That means expectations for the stock are sky high, and any slowdown in growth or hiccup in execution could send shares tumbling. International commercial adoption remains a weak spot, with revenue in that segment down slightly last quarter, so the company still has work to do in proving it can scale globally outside its government and U.S. commercial strongholds. And while the company hasn't felt an impact from U.S. government spending cuts, other defense contractors have, so it is still something to at least keep an eye on. The massive opportunity ahead Despite those risks, Palantir's opportunity is hard to ignore. AIP appears to be a game-changing platform for Palantir, capable of providing real-world analysis across seemingly any industry. The breadth of use cases for AIP is just incredible; it's being used for everything from monitoring sepsis at hospitals to helping insurance companies with their underwriting to helping companies with their supply chains. Many customers are still in the early stages of deployment, which means the opportunity for increased usage and more use cases within these customers is a huge opportunity. The company is also rolling out AI agents that can take even more direct action and handle specific automated tasks, which could further increase the platform's stickiness and impact. And with European commercial markets largely untapped, Palantir has another major growth lever. Palantir's stock is pricey, although great companies rarely trade at bargain prices. If it can maintain its AI leadership position and continue expanding its reach, the stock has the potential to be one of the defining AI investments of the next decade. Should you invest $1,000 in Palantir Technologies right now? Before you buy stock in Palantir Technologies, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Palantir Technologies wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,155!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,106,071!* Now, it's worth noting Stock Advisor's total average return is 1,070% — a market-crushing outperformance compared to 184% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 18, 2025 Geoffrey Seiler has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Palantir Technologies. The Motley Fool has a disclosure policy. Meet the Monster Stock That Continues to Crush the Market was originally published by The Motley Fool Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
MBX Biosciences Submits IND for Once-Monthly Obesity Drug
MBX Biosciences Inc. (NASDAQ:MBX) is one of the best IPO stocks to buy according to Wall Street analysts. On June 16, MBX Biosciences announced the submission of an Investigational New Drug/IND application to the US FDA for MBX 4291. This drug is a long-acting GLP-1/GIP receptor co-agonist prodrug being developed for the treatment of obesity. The company's President and CEO, Kent Hawryluk, stated that MBX 4291 is designed to be a potential once-monthly injectable, which could offer less frequent dosing and improved gastrointestinal tolerability, potentially leading to better patient adherence and increased weight loss. MBX 4291 was created using the company's proprietary Precision Endocrine Peptide/PEP platform. A doctor holding a test tube of the biopharmaceutical company's NicAlert drug product while providing patient care. In preclinical studies, the active component of MBX 4291 demonstrated a similar activity profile and body weight loss as tirzepatide, a weekly GLP-1/GIP co-agonist that is already approved. Furthermore, these preclinical studies showed an extended duration of action for MBX 4291's active component compared to tirzepatide, supporting the potential for once-monthly administration. MBX Biosciences Inc. (NASDAQ:MBX) is a clinical-stage biopharmaceutical company that discovers and develops precision peptide therapies for the treatment of endocrine and metabolic disorders. While we acknowledge the potential of MBX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
3 hours ago
- Business Insider
Guggenheim Remains a Buy on Nexstar Media Group (NXST)
In a report released today, Curry Baker from Guggenheim maintained a Buy rating on Nexstar Media Group, with a price target of $250.00. The company's shares closed today at $207.73. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Baker covers the Communication Services sector, focusing on stocks such as Liberty Media Liberty Formula One, Liberty Media Liberty Formula One, and Live Nation Entertainment. According to TipRanks, Baker has an average return of 12.4% and a 64.17% success rate on recommended stocks. In addition to Guggenheim, Nexstar Media Group also received a Buy from Barrington's Patrick Sholl in a report issued today. However, on August 15, Citi maintained a Hold rating on Nexstar Media Group (NASDAQ: NXST).
